Windtree Therapeutics Leadership

Eric Curtis is a Senior VP/COO at WINDTREE THERAPEUTICS INC DE and is based in Jamison, Pennsylvania. He has worked as VP & GM, Rare Disease/Cardiopulmonary BU at Bayer; President/COO at CYTRX CORP; and President, US Commercial at Amryt Pharma Aegerion Pharmaceuticals Division. Eric studied at Penn State University and University of Pittsburgh.

John joined Windtree in July 2020 with more than 30 years of financial leadership experience in the pharmaceutical, biopharmaceutical, and clinical research sectors. He has broad-based experience in financial, administrative, information technology, and facility functions, in addition to his success in completing IPO and follow-on offerings for several pharmaceutical companies. John most recently provided consulting services to various life science companies, headed up finance at Trevena, Inc., where he was instrumental in successfully raising equity; NephroGenex, Inc., where he actively led the IPO and subsequent financial restructuring and sale of the company; Savient Pharmaceuticals, where he led a sale process resulting in $120 million in proceeds; and PharmaNet where he successfully completed its sale for approximately $250 million, which then became known as PharmaNet Development Group, where he directed financial and administrative operations for the company.

John received a B.S. in Accounting and Business and Computer Science from DeSales University and is a certified public accountant.

Steve was appointed Windtree’s Vice President of Clinical Development in May of 2014 and has served as the Company’s Senior Vice President and Chief Medical Officer since October 2014.

Steve has a significant background in pulmonary critical care, with more than 25 years of medical practice and pharmaceutical industry clinical trial expertise including all phases of drug development. Prior to joining Windtree, Steve held executive positions with several companies including Executive Director in the Molecular Development Group at Covance, Vice President of Clinical Development at Agennix, Inc., and various positions at AstraZeneca, where he spent 15 years in medical and clinical leadership.

Steve received his medical degree from the Medical College of Wisconsin, his Masters of Health Sciences degree in Biometry from Duke University School of Medicine, and completed his training in internal medicine followed by a fellowship in pulmonary and critical care medicine at Duke University Medical Center.